Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENDRA Life Sciences (NDRA) EBT Margin (2016 - 2018)

Historic EBT Margin for ENDRA Life Sciences (NDRA) over the last 3 years, with Q1 2018 value amounting to 45761.31%.

  • ENDRA Life Sciences' EBT Margin changed N/A to 45761.31% in Q1 2018 from the same period last year, while for Dec 2018 it was 158669.6%, marking a year-over-year decrease of 1571404100.0%. This contributed to the annual value of 10607.97% for FY2024, which is 84232600.0% down from last year.
  • Latest data reveals that ENDRA Life Sciences reported EBT Margin of 45761.31% as of Q1 2018.
  • ENDRA Life Sciences' 5-year EBT Margin high stood at 310.52% for Q2 2016, and its period low was 45761.31% during Q1 2018.
  • Its 3-year average for EBT Margin is 13646.3%, with a median of 1397.52% in 2017.
  • Within the past 5 years, the most significant YoY rise in ENDRA Life Sciences' EBT Margin was -27888700bps (2017), while the steepest drop was -333647800bps (2017).
  • ENDRA Life Sciences' EBT Margin (Quarter) stood at 133.61% in 2016, then plummeted by -24971bps to 33498.39% in 2017, then plummeted by -37bps to 45761.31% in 2018.
  • Its last three reported values are 45761.31% in Q1 2018, 33498.39% for Q4 2017, and 316.69% during Q3 2017.